The platelet P2Y12 receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [3H]PSB-0413

[1]  P. Ohlmann,et al.  β-arrestin-1 participates in thrombosis and regulates integrin αIIbβ3 signalling without affecting P2Y receptors desensitisation and function , 2012, Thrombosis and Haemostasis.

[2]  S. Mundell,et al.  An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets. , 2011, Blood.

[3]  M. Cattaneo.  Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate , 2011, Thrombosis and Haemostasis.

[4]  M. Cattaneo.  The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects. , 2011, Blood.

[5]  M. Cattaneo.  Molecular defects of the platelet P2 receptors , 2011, Purinergic Signalling.

[6]  D. Summa,et al.  The role of protein sulfhydryl groups and protein disulfides of the platelet surface in aggregation processes involving thiol exchange reactions. , 2011, Pharmacological research.

[7]  K. Jacobson,et al.  Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500). , 2010, Pharmacological research.

[8]  K. Jacobson,et al.  P2Y nucleotide receptors: promise of therapeutic applications. , 2010, Drug discovery today.

[9]  M. Cattaneo.  New P2Y12 Inhibitors , 2010, Circulation.

[10]  Meryem Köse,et al.  High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. , 2009, Journal of medicinal chemistry.

[11]  H. Katus,et al.  Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. , 2009, International journal of cardiology.

[12]  M. Lohse,et al.  Agonist-selective, Receptor-specific Interaction of Human P2Y Receptors with β-Arrestin-1 and -2* , 2008, Journal of Biological Chemistry.

[13]  E. Schwedhelm,et al.  P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease. , 2008, British journal of clinical pharmacology.

[14]  C. Gachet.  P2 receptors, platelet function and pharmacological implications , 2008, Thrombosis and Haemostasis.

[15]  Geoffrey Burnstock,et al.  Physiology and pathophysiology of purinergic neurotransmission. , 2007, Physiological reviews.

[16]  S. Mundell,et al.  Distinct Clathrin‐Coated Pits Sort Different G Protein‐Coupled Receptor Cargo , 2006, Traffic.

[17]  K. Jacobson,et al.  [32P]2‐iodo‐N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors , 2006, British journal of pharmacology.

[18]  C. Gachet.  Regulation of platelet functions by P2 receptors. , 2006, Annual review of pharmacology and toxicology.

[19]  C. Müller,et al.  Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors. , 2005, Bioorganic & medicinal chemistry letters.

[20]  P. Fontana,et al.  LETTER TO THE EDITOR: P2Y1 gene polymorphism and ADP‐induced platelet response , 2005, Journal of thrombosis and haemostasis : JTH.

[21]  S. Mundell,et al.  P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. , 2005, Blood.

[22]  J. Herbert,et al.  Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. , 2005, Seminars in thrombosis and hemostasis.

[23]  J. Galzi,et al.  Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties? , 2005, Molecular Pharmacology.

[24]  J. Cazenave,et al.  Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor , 2004, Journal of thrombosis and haemostasis : JTH.

[25]  J. Cazenave,et al.  Preparation of washed platelet suspensions from human and rodent blood. , 2004, Methods in molecular biology.

[26]  P. Fontana,et al.  P2Y12 H2 Haplotype Is Associated With Peripheral Arterial Disease: A Case-Control Study , 2003, Circulation.

[27]  P. Fontana,et al.  Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects , 2003, Circulation.

[28]  S. Kunapuli,et al.  Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. , 2003, Blood.

[29]  J. Ware,et al.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Bourguignon,et al.  Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. , 2001, European journal of pharmacology.

[31]  J. Cazenave,et al.  Desensitization of the Platelet Aggregation Response to ADP: Differential Down-regulation of the P2Y1 and P2cyc Receptors , 2000, Thrombosis and Haemostasis.

[32]  P. Mannucci,et al.  Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors , 1995, British journal of haematology.

[33]  J. Herbert,et al.  Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine. , 1994, The Journal of pharmacology and experimental therapeutics.

[34]  G. Cristalli,et al.  Identification of a receptor for ADP on blood platelets by photoaffinity labelling. , 1993, The Biochemical journal.

[35]  P. Mannucci,et al.  Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. , 1992, Blood.

[36]  Broekman Mj.  Homogenization by nitrogen cavitation technique applied to platelet subcellular fractionation. , 1992 .

[37]  D. Macfarlane.  2-Methylthioadenosine [beta-32P]diphosphate: synthesis and use as probe of platelet ADP receptors. , 1992, Methods in enzymology.

[38]  G. Jamieson,et al.  Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues , 1988 .

[39]  D. Macfarlane,et al.  2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. , 1983, The Journal of clinical investigation.

[40]  D. Macfarlane.  The effects of methyl mercury on platelets: induction of aggregation and release via activation of the prostaglandin synthesis pathway. , 1981, Molecular pharmacology.

[41]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[42]  J. Sixma,et al.  Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes. , 1980, Biochimica et biophysica acta.

[43]  A. J. Barber,et al.  Isolation and characterization of plasma membranes from human blood platelets. , 1970, The Journal of biological chemistry.